Medicare Advantage plans must now reveal what supplemental benefits they're actually delivering

What it does

This bill requires Medicare Advantage plans to report detailed, enrollee-level data on supplemental benefits (dental, vision, hearing, transportation, etc.) to the federal government starting in 2029, and mandates that the government publish this data publicly each October beginning in 2030 so researchers, policymakers, and the public can analyze what benefits are actually being offered and used. The data will be stripped of personal identifiers to protect privacy.

Why we flagged it

The bill's sole operative mechanism is a data-reporting and public-disclosure requirement. It does not change benefit rules, eligibility, or payment rates—only mandates transparency into what MA plans are already offering and how enrollees are using supplemental benefits.

What the text implies

• MA organizations will face compliance costs to collect, format, and submit enrollee-level data; these costs may be passed through to plans or absorbed as administrative expense, potentially affecting plan pricing or profit margins.
• Public availability of utilization and payment data may enable competitive pressure on MA plans to expand or improve supplemental benefits, or conversely may reveal disparities in benefit offerings across plans and regions.
• The data release may support future regulatory or legislative action to standardize supplemental benefits or address gaps, depending on what the data reveals about current offerings and utilization patterns.
• Researchers and advocacy groups will gain a new evidence base for analyzing whether supplemental benefits are reaching intended populations and whether out-of-pocket costs are creating barriers to access.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Ordinary citizens and researchers gain transparency into what supplemental benefits Medicare Advantage plans are offering and how they are being used, enabling informed plan selection and evidence-based policy. MA organizations face a new reporting burden but no direct cost to enrollees, and the data release supports public accountability in a market where benefit offerings are currently opaque.

Named in the bill

Medicare Advantage (MA) organizations, Centers for Medicare & Medicaid Services (CMS), Social Security Act § 1857(e), Department of Health and Human Services (HHS)

Where it stands

1 cosponsor: 1 Republicans.

• Sep 10, 2025 — Introduced · Congress.gov: “Introduced in House”
• Sep 10, 2025 — Referred to House Committee on Energy and Commerce and House Committee on Ways and Means · Congress.gov: “Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a…”
• Jun 25, 2026 — Markup held in committee · Congress.gov: “Subcommittee Consideration and Mark-up Session Held”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

4 lobbying clients named this bill on 5 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $2,516,347 in lobbying spend. A filing names 21 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 72% of bills with at least one filing.

Jennifer McClellan, the sponsor, reported $699,956 in PAC receipts in the 2026 cycle.

• Better Medicare Alliance, Inc. — $950,000 on 2 filings
• Cambia Health Solutions — $700,000 on 1 filing
• Blood Cancer United (fka the Leukemia & Lymphoma Society) — $590,000 on 1 filing
• Blue Cross Blue Shield of Michigan — $276,347 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.